Koers LexaGene Holdings Inc. Toronto S.E.
Aandelen
LXG.H
CA52886L1031
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jack Regan
CEO | Chief Executive Officer | - | 26-04-07 |
Jeffrey Mitchell
DFI | Director of Finance/CFO | - | 01-03-18 |
Steven Armstrong
COO | Chief Operating Officer | - | 24-03-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Joseph P. Caruso
BRD | Director/Board Member | 65 | 18-06-18 |
Jack Regan
CEO | Chief Executive Officer | - | 26-04-07 |
Tom Slezak
BRD | Director/Board Member | - | 12-10-16 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-16,10% | 11,13 mld. | |
+67,65% | 3,6 mld. | |
-30,20% | 2,26 mld. | |
-14,31% | 2,16 mld. | |
-26,03% | 1,54 mld. | |
+36,95% | 1,17 mld. | |
-2,40% | 744 mln. | |
-38,57% | 432 mln. | |
+13,72% | 357 mln. |